Kathleen Borthwick, CFO of Passage BIO, Inc. ($PASG), made one open market sale of common shares in the last year, totaling $38,022. Her most recent sale occurred on January 8, 2026. This activity ranks her 10,652nd out of 11,678 insiders by sales volume, well below the average of $8.6 million across 6.37 transactions per insider. She reported no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 16, 2026 | Passage BIO, Inc. | $PASG | Borthwick Kathleen | CFO | A | Employee Stock Option (right to buy) | 15610 | $0.00 | 15,610.0000 | 3,172,870 | 9999.99% | 0.49% |
| Jan. 8, 2026 | Passage BIO, Inc. | $PASG | Borthwick Kathleen | CFO | M | Restricted Stock Unit | 5000 | $0.00 | 5,000.0000 | 3,172,870 | 50.00% | 0.16% |
| Jan. 8, 2026 | Passage BIO, Inc. | $PASG | Borthwick Kathleen | CFO | M | Common Stock | 5000 | $0.00 | 7,464.0000 | 3,172,870 | 202.92% | 0.16% |
| Jan. 8, 2026 | Passage BIO, Inc. | $PASG | Borthwick Kathleen | CFO | S | Common Stock | 2062 | $18.44 | 5,402.0000 | 3,172,870 | 27.63% | 0.06% |
| Jan. 15, 2025 | Passage BIO, Inc. | $PASG | Borthwick Kathleen | CFO | A | Restricted Stock Unit | 10000 | $0.00 | 10,000.0000 | 3,078,665 | 9999.99% | 0.32% |
| March 15, 2025 | Passage BIO, Inc. | $PASG | Borthwick Kathleen | CFO | A | Employee Stock Option (right to buy) | 278386 | $0.00 | 278,386.0000 | 3,078,665 | 9999.99% | 9.04% |
| Feb. 10, 2025 | Passage BIO, Inc. | $PASG | Borthwick Kathleen | CFO | M | Restricted Stock Unit | 8000 | $0.00 | 0.0000 | 3,078,665 | 100.00% | 0.26% |
| Feb. 10, 2025 | Passage BIO, Inc. | $PASG | Borthwick Kathleen | CFO | M | Common Stock | 8000 | $0.00 | 44,466.0000 | 3,078,665 | 21.94% | 0.26% |
| Feb. 11, 2025 | Passage BIO, Inc. | $PASG | Borthwick Kathleen | CFO | S | Common Stock | 3183 | $0.53 | 41,283.0000 | 3,078,665 | 7.16% | 0.10% |
| March 15, 2024 | Passage BIO, Inc. | $PASG | Borthwick Kathleen | CFO | A | Employee Stock Option (right to buy) | 227000 | $0.00 | 227,000.0000 | 54,743,490 | 9999.99% | 0.41% |
| Feb. 10, 2024 | Passage BIO, Inc. | $PASG | Borthwick Kathleen | SVP, INTERIM CFO | M | Restricted Stock Unit | 4000 | $0.00 | 8,000.0000 | 54,743,490 | 33.33% | 0.01% |
| Feb. 10, 2024 | Passage BIO, Inc. | $PASG | Borthwick Kathleen | SVP, INTERIM CFO | M | Common Stock | 4000 | $0.00 | 29,936.0000 | 54,743,490 | 15.42% | 0.01% |
| Feb. 13, 2024 | Passage BIO, Inc. | $PASG | Borthwick Kathleen | SVP, INTERIM CFO | S | Common Stock | 1470 | $0.97 | 28,466.0000 | 54,743,490 | 4.91% | 0.00% |
| Dec. 31, 2023 | Passage BIO, Inc. | $PASG | Borthwick Kathleen | SVP, Interim CFO | M | Common Stock | 30000 | $0.00 | 36,608.0000 | 54,789,410 | 454.00% | 0.05% |
| Jan. 2, 2024 | Passage BIO, Inc. | $PASG | Borthwick Kathleen | SVP, Interim CFO | S | Common Stock | 10672 | $0.91 | 25,936.0000 | 54,743,490 | 29.15% | 0.02% |
| Dec. 31, 2023 | Passage BIO, Inc. | $PASG | Borthwick Kathleen | SVP, Interim CFO | M | Restricted Stock Unit | 30000 | $0.00 | 0.0000 | 54,789,410 | 100.00% | 0.05% |
| July 28, 2023 | Passage BIO, Inc. | $PASG | Borthwick Kathleen | SVP, Interim CFO | A | Employee Stock Option (right to buy) | 20000 | $0.00 | 20,000.0000 | 54,683,817 | 9999.99% | 0.04% |